TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 16, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Net Income towards Common Stockholders Growth (1y) (2021 - 2023)

Analysis

TFA Therapeutics (RAJAF) Net Income towards Common Stockholders Growth (1y) (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Colgate Palmolive 69.71 Bn 68.67 Bn 3.30 Bn -6.99%
2 Kenvue 34.22 Bn 33.11 Bn 2.30 Bn 8.57%
3 Kimberly Clark 32.55 Bn 31.72 Bn 1.60 Bn -36.56%
4 Bath & Body Works 3.52 Bn 2.73 Bn 692.00 Mn 84.38%
5 Prestige Consumer Healthcare 2.52 Bn 2.46 Bn - -
6 Perrigo 1.88 Bn 1.49 Bn 313.90 Mn 985.71%
7 Edgewell Personal Care 1.25 Bn 854.93 Mn 242.50 Mn -52.92%
8 Herbalife 1.25 Bn 883.17 Mn 1.03 Bn -153.86%
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 611.15 Mn 505.26 Mn 40.36 Mn 176.15%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 116.85%
Dec 31, 2022 8.01%
Dec 31, 2021 -2,657.69%